Intradermal cholera vaccination
- 1 March 1964
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 62 (1) , 11-23
- https://doi.org/10.1017/s0022172400039723
Abstract
The protection afforded by cholera vaccine administered by the intradermal route, and demonstrated by active and passive mouse protection tests, active guinea-pig protection tests, and agglutination titres, is excellent and equal to that given by subcutaneous inoculation.It is suggested that cholera vaccine administered by the intradermal route would greatly reduce the incidence of reactions which occur when the vaccine is given subcutaneously.Keywords
This publication has 10 references indexed in Scilit:
- Cholera Vaccines and the El Tor VibrioBMJ, 1963
- REACTIONS TO INTRADERMAL T.A.B.T. AND T.A.B. VACCINES.1963
- INTRADERMAL T.A.B.T. VACCINE FOR IMMUNISATION AGAINST ENTERICThe Lancet, 1959
- The toxicity of intracutaneous T.A.B. vaccine.1958
- Proposed standard agglutinating sera for typhoid and paratyphoid A and B fevers.1954
- CHOLERA IMMUNIZATION1948
- Studies on Immunity to Asiatic Cholera: III. The Mouse Protection TestThe Journal of Infectious Diseases, 1947
- Mouse Protective Antibodies in Human Serums following Injections with Cholera VaccinePublic Health Reports (1896-1970), 1944
- The Antigens of the Cholera Group of VibriosEpidemiology and Infection, 1935